Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076087 · ClinicalTrials.gov registry record
Immune Characterization of Subcutaneous Adipose Tissue
A clinical trial of Determine Immune Cell Types in Subcutaneous Adipose Tissue, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 19
- Enrollment target
- 1
- Study location
NCT02076087: Completed study of Determine Immune Cell Types in Subcutaneous Adipose Tissue, sponsored by Washington University School of Medicine.
NCT02076087 is a study of Determine Immune Cell Types in Subcutaneous Adipose Tissue that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076087, a study of Determine Immune Cell Types in Subcutaneous Adipose Tissue, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this proposal is to characterize the immune cell profile of subcutaneous abdominal adipose tissue in lean, overweight, obese and lipedema adults, and to evaluate potential associations between different adipose tissue immune cell types and metabolic profile.
Conditions Studied
Interventions
- PROCEDURE Liposuction/lipectomy
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-09 |
What the finished NCT02076087 record still lists
NCT02076087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 1 condition, with Determine Immune Cell Types in Subcutaneous Adipose Tissue appearing as the primary indexed condition, and to 1 intervention - of which Liposuction/lipectomy is the first listed.
NCT02076087 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02076087 about?
NCT02076087 is a clinical study titled "Immune Characterization of Subcutaneous Adipose Tissue". The overall goal of this proposal is to characterize the immune cell profile of subcutaneous abdominal adipose tissue in lean, overweight, obese and lipedema adults, and to evaluate potential associations between different adipose tissue immune cell types and metabolic profile.
What is the current status of trial NCT02076087?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2014-02. Estimated completion is 2017-09.
What conditions does trial NCT02076087 study?
This clinical trial studies the following conditions: Determine Immune Cell Types in Subcutaneous Adipose Tissue.
What interventions are being tested in trial NCT02076087?
The interventions under investigation include: Liposuction/lipectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02076087?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02076087 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia